PT923308E - Purificacao de peptideos a partir do leite biologicamente activos - Google Patents

Purificacao de peptideos a partir do leite biologicamente activos

Info

Publication number
PT923308E
PT923308E PT97923643T PT97923643T PT923308E PT 923308 E PT923308 E PT 923308E PT 97923643 T PT97923643 T PT 97923643T PT 97923643 T PT97923643 T PT 97923643T PT 923308 E PT923308 E PT 923308E
Authority
PT
Portugal
Prior art keywords
milk
purification
peptide
biologically active
permeate
Prior art date
Application number
PT97923643T
Other languages
English (en)
Portuguese (pt)
Inventor
Joseph P Kutzko
Michael L Hayes
Lee T Sherman
Original Assignee
Genzyme Transgenics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Transgenics Corp filed Critical Genzyme Transgenics Corp
Publication of PT923308E publication Critical patent/PT923308E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT97923643T 1996-05-13 1997-05-13 Purificacao de peptideos a partir do leite biologicamente activos PT923308E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/648,235 US6268487B1 (en) 1996-05-13 1996-05-13 Purification of biologically active peptides from milk

Publications (1)

Publication Number Publication Date
PT923308E true PT923308E (pt) 2002-11-29

Family

ID=24599969

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97923643T PT923308E (pt) 1996-05-13 1997-05-13 Purificacao de peptideos a partir do leite biologicamente activos

Country Status (14)

Country Link
US (1) US6268487B1 (cg-RX-API-DMAC7.html)
EP (1) EP0923308B1 (cg-RX-API-DMAC7.html)
JP (1) JP4476362B2 (cg-RX-API-DMAC7.html)
AT (1) ATE224145T1 (cg-RX-API-DMAC7.html)
AU (1) AU725993B2 (cg-RX-API-DMAC7.html)
CA (1) CA2254871C (cg-RX-API-DMAC7.html)
DE (2) DE69715641T2 (cg-RX-API-DMAC7.html)
DK (1) DK0923308T3 (cg-RX-API-DMAC7.html)
ES (1) ES2182074T3 (cg-RX-API-DMAC7.html)
LU (1) LU91305I2 (cg-RX-API-DMAC7.html)
NL (1) NL300256I2 (cg-RX-API-DMAC7.html)
NZ (1) NZ332916A (cg-RX-API-DMAC7.html)
PT (1) PT923308E (cg-RX-API-DMAC7.html)
WO (1) WO1997042835A1 (cg-RX-API-DMAC7.html)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000007I1 (de) 1986-04-09 2007-05-16 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
CN1179048C (zh) 1997-10-20 2004-12-08 Gtc生物治疗学公司 修饰的MSP-1核酸序列以及增加细胞系统中mRNA水平和蛋白质表达的方法
SE9802213D0 (sv) * 1998-06-18 1998-06-18 Amersham Pharm Biotech Ab A method for the removal/purification of serum albumins and means for use in the method
US20030005468A1 (en) * 1998-06-19 2003-01-02 Meade Harry M. Methods and vectors for improving nucleic acid expression
ATE328007T1 (de) * 1998-09-24 2006-06-15 Pharming Intellectual Pty Bv Reinigung von fibrinogen aus flüssigkeiten mittels ausfällung und hydrophobischer- interaktion-chromatographie
CA2354638C (en) * 1999-01-06 2013-03-19 Atlantic Biopharmaceuticals, Inc. Expression of secreted human alpha-fetoprotein in transgenic animals
WO2001000855A1 (en) 1999-06-23 2001-01-04 Ppl Therapeutics (Scotland) Ltd. Fusion proteins incorporating lysozyme
AU5946501A (en) * 2000-05-05 2001-11-20 Genzyme Transgenics Corp Transgenically produced decorin
US20020077775A1 (en) * 2000-05-25 2002-06-20 Schork Nicholas J. Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20030195707A1 (en) * 2000-05-25 2003-10-16 Schork Nicholas J Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20040226052A1 (en) * 2000-10-13 2004-11-11 Meade Harry M. Methods of producing a target molecule in a transgenic animal and purification of the target molecule
NZ529767A (en) * 2001-06-13 2005-10-28 Taurus Hsa Llc Purification of human serum albumin
CA2456571A1 (en) * 2001-08-10 2003-02-20 Genset Sa Human secreted proteins, their encoding polynucleotides, and uses thereof
US6875459B2 (en) * 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
US20060253913A1 (en) * 2001-12-21 2006-11-09 Yue-Jin Huang Production of hSA-linked butyrylcholinesterases in transgenic mammals
WO2003090545A1 (en) * 2002-04-24 2003-11-06 Dairy Development Specialists, Inc. Intermediate ingredient for dairy product manufacturing and method of making the same
DE60227922D1 (de) * 2002-05-27 2008-09-11 Nestec Sa Säurelösliche Proteine aus Casein-Micellen
GB0216001D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
AU2003267135A1 (en) * 2002-09-17 2004-04-08 Gtc Biotherapeutics, Inc. Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
CA2506629A1 (en) * 2002-11-27 2004-06-17 Gtc Biotherapeutics, Inc. Modified antibodies stably produced in milk and methods of producing same
US20040210953A1 (en) * 2003-01-09 2004-10-21 Murray James D. Lysozyme transgenic ungulates
US20040231010A1 (en) * 2003-01-09 2004-11-18 Murray James D. Lysozyme transgenic ungulates
ES2371913T3 (es) 2003-01-22 2012-01-11 Duke University Constructos mejorados para expresar polipéptidos lisosomales.
US20040167320A1 (en) * 2003-02-24 2004-08-26 Couto Daniel E. Methods of tangential flow filtration and an apparatus therefore
WO2005085287A1 (en) 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
US20050197496A1 (en) * 2004-03-04 2005-09-08 Gtc Biotherapeutics, Inc. Methods of protein fractionation using high performance tangential flow filtration
US20050245444A1 (en) * 2004-04-30 2005-11-03 Yann Echelard Method of using recombinant human antithrombin for neurocognitive disorders
US20060121004A1 (en) * 2004-12-07 2006-06-08 Yann Echelard Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
US20060130159A1 (en) * 2004-12-09 2006-06-15 Nick Masiello Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
US20080019905A9 (en) * 2005-02-18 2008-01-24 Strome Scott E Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
WO2006138647A2 (en) * 2005-06-16 2006-12-28 Gtc Biotherapeutics, Inc. Method of making recombinant human antibodies for use in biosensor technology
US20070037192A1 (en) * 2005-07-25 2007-02-15 Gtc Biotherapeutics, Inc. Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile
CN101484470B (zh) * 2005-10-21 2014-07-23 阿伊沃生物制剂有限公司 具有增强的抗体依赖性细胞毒性活性的抗体及其生产方法和用途
US7531632B2 (en) * 2006-02-16 2009-05-12 Gtc Biotherapeutics, Inc. Clarification of transgenic milk using depth filtration
FR2901707B1 (fr) 2006-05-31 2017-09-29 Lab Francais Du Fractionnement Composition de facteur vii recombinant ou transgenique, chaque molecule de facteur vii possedant deux sites de n-glycosylation a motifs glycanniques definis
CA2659809A1 (en) * 2006-08-04 2008-02-14 Pharmathene Inc. Long half-life recombinant butyrylcholinesterase
FR2910786B1 (fr) * 2006-12-29 2017-08-11 Laboratoire Francais Du Fractionnement Et Des Biotechnologies (Lfb) "procede d'extraction d'une proteine presente dans du lait"
JP5208428B2 (ja) * 2007-01-30 2013-06-12 雪印メグミルク株式会社 美肌剤
FR2912310B1 (fr) 2007-02-13 2009-08-07 Kasan Sarl Nouvelles compositions cosmetiques et/ou pharmaceutiques et leurs applications.
ES2518290T3 (es) 2007-07-10 2014-11-04 Glanbia Nutritionals (Ireland) Limited Método de eliminación de endotoxinas de proteínas
TWI346666B (en) * 2007-12-31 2011-08-11 Animal Technology Inst Taiwan Method for seperating casein from casein-contained solution
EP2077273B1 (en) 2007-12-31 2011-09-14 Animal Technology Institute Taiwan Methods for separating casein from soluble proteins in a composition
US8304005B2 (en) * 2008-04-21 2012-11-06 Fuji Oil Company, Limited Method for production of defatted soymilk peptide
EP2279003A4 (en) * 2008-05-01 2013-04-03 Gtc Biotherapeutics Inc ANTI-CD137 ANTIBODY AS A MEANS FOR THE TREATMENT OF INFLAMMATORY DISEASES
BRPI0911957A2 (pt) * 2008-05-14 2016-08-23 Agriculture Victoria Serv Pty frações de leite enriquecidas com angiogenina
EP4328305A3 (en) * 2009-12-18 2024-08-14 CSL Ltd. Method of purifying polypeptides
AU2010340358B2 (en) 2009-12-21 2014-07-24 Pharmathene, Inc. Recombinant butyrylcholinesterases and truncates thereof
US8861162B2 (en) * 2010-03-09 2014-10-14 Honeywell International Inc. High power solid state power controller (SSPC) solution for primary power distribution applications
FR2958496A1 (fr) * 2010-04-09 2011-10-14 Bioprotein Technologies Sa Preparation de proteine plasmatique de transfert des phospholipides (pltp) humaine recombinante a partir du lait d'animaux transgeniques.
CN104959052B (zh) 2010-04-09 2018-07-13 帕西拉制药有限公司 用于配制大直径合成膜囊泡的方法
US10138290B2 (en) 2010-10-05 2018-11-27 Novo Nordisk Healthcare Ag Process for protein production
CN103429272A (zh) 2010-12-30 2013-12-04 法国化学与生物科技实验室 作为病原体灭活剂的二元醇
US11154821B2 (en) 2011-04-01 2021-10-26 Emd Millipore Corporation Nanofiber containing composite membrane structures
AU2012278836B2 (en) * 2011-07-07 2016-03-10 Lfb Usa, Inc. Formulations that stabilize proteins
TW201400499A (zh) 2012-03-12 2014-01-01 Revo Biolog Inc 抗凝血酶用於治療妊娠毒血症之用途
EP2687595B1 (en) 2012-07-19 2018-05-30 Laboratoire Français du Fractionnement et des Biotechnologies Method for purifying transgenic factor VII
WO2014022748A1 (en) 2012-08-03 2014-02-06 Revo Biologics, Inc. The use of antithrombin in extracorporeal membrane oxygenation
KR20160002713A (ko) 2013-02-13 2016-01-08 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도
CN105263319A (zh) 2013-02-13 2016-01-20 法国化学与生物科技实验室 具有经修饰的糖基化的蛋白及其生产方法
MX384222B (es) 2013-07-05 2025-03-14 Lab Francais Du Fractionnement Matriz de cromatografia de afinidad.
US9661868B2 (en) * 2013-07-16 2017-05-30 Mead Johnson Nutrition Company Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin
AR100716A1 (es) * 2014-06-02 2016-10-26 Laboratoire Français Du Fractionnement Et Des Biotechnologies Producción de fragmentos fc
SG11201608399QA (en) 2014-06-26 2016-11-29 Emd Millipore Corp Filter structure with enhanced dirt holding capacity
FR3034419B1 (fr) 2015-04-02 2017-12-15 Lab Francais Du Fractionnement Procede de purification d'une proteine recombinante therapeutique a partir d'un lait transgenique
KR102206959B1 (ko) 2015-04-17 2021-01-25 이엠디 밀리포어 코포레이션 접선방향 유동 여과 모드에서 작동되는 나노섬유 한외여과막을 사용하여 샘플에서 목적하는 생물학적 물질을 정제하는 방법
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
EP3655142A1 (en) 2017-07-21 2020-05-27 Merck Millipore Ltd Non-woven fiber membranes
CA3100869A1 (en) * 2018-05-24 2019-11-28 Jiangsu Hengrui Medicine Co., Ltd. Method for preparing precursor of recombinant human insulin or analogue thereof
FR3082427B1 (fr) 2018-06-14 2020-09-25 Lab Francais Du Fractionnement Combinaison de facteur vii et d'un anticorps bispecifique anti-facteurs ix et x
JP7478333B2 (ja) * 2020-07-29 2024-05-07 和弘 原 成分調整物生産装置及び成分調整物生産方法
CN113101737B (zh) * 2021-03-04 2023-09-15 京美生命科技(杭州)有限公司 一种亲和切向流过滤系统及其构建方法和外泌体提取方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
FR2487642B2 (fr) 1980-07-31 1985-10-18 Bel Fromageries Procede de preparation de fractions proteiques par ultrafiltration et chromatographie d'exclusion et d'echange d'ions
DE3432718C1 (de) 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
FR2584727B1 (fr) 1985-07-11 1988-06-17 Roussel Uclaf Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
JPS62298536A (ja) 1986-06-17 1987-12-25 Green Cross Corp:The 生理活性物質の自動精製方法および自動精製装置
DE3743440A1 (de) * 1987-12-21 1989-06-29 Gauri Kailash Kumar Verfahren zum trennen der geloesten und ungeloesten bestandteile von milch
US4897465A (en) 1988-10-12 1990-01-30 Abbott Laboratories Enrichment and concentration of proteins by ultrafiltration
MC2211A1 (fr) 1989-12-01 1992-11-26 Genpharm Int Production de polypeptides recombinants par une espece bovine et procedes transgeniques
NL9001650A (nl) 1990-07-19 1992-02-17 Ver Coop Melkind Werkwijze voor de bereiding van een melkeiwit-isolaat.
US5256294A (en) * 1990-09-17 1993-10-26 Genentech, Inc. Tangential flow filtration process and apparatus
US5175013A (en) 1990-12-31 1992-12-29 The Pillsbury Company Frozen dessert compositions and products
US5178894A (en) 1991-09-26 1993-01-12 Silvia P. Rudel High non-fat milk content bread products having improved keeping qualities
EP0652889A4 (en) 1992-06-15 1997-05-07 Gene Pharming Europ Bv PRODUCTION OF RECOMBINANT POLYPEPTIDES BY BOVINE SPECIES AND TRANSGENIC PROCESSES.
US5256437A (en) * 1992-06-19 1993-10-26 Pall Corporation Product and process of making sterile milk through dynamic microfiltration
ES2146648T3 (es) 1993-03-09 2000-08-16 Genzyme Corp Procedimiento de aislamiento de proteinas de la leche.
AU1809895A (en) 1994-02-16 1995-09-04 Pharming Bv Isolation of lactoferrin from milk
US5597486A (en) * 1995-05-01 1997-01-28 Millipore Investment Holdings Limited Membrane filtration with optimized addition of second liquid to maximize flux

Also Published As

Publication number Publication date
NL300256I2 (nl) 2007-09-03
DE122007000008I2 (de) 2011-01-13
NZ332916A (en) 2000-05-26
DE122007000008I1 (de) 2009-05-20
DK0923308T3 (da) 2002-10-14
AU2940297A (en) 1997-12-05
JP4476362B2 (ja) 2010-06-09
DE69715641T2 (de) 2003-08-07
ATE224145T1 (de) 2002-10-15
JP2000510701A (ja) 2000-08-22
NL300256I1 (nl) 2007-04-02
ES2182074T3 (es) 2003-03-01
WO1997042835A1 (en) 1997-11-20
LU91305I2 (fr) 2007-03-12
CA2254871C (en) 2008-03-25
EP0923308A1 (en) 1999-06-23
AU725993B2 (en) 2000-10-26
EP0923308B1 (en) 2002-09-18
EP0923308A4 (cg-RX-API-DMAC7.html) 1999-06-30
US6268487B1 (en) 2001-07-31
DE69715641D1 (de) 2002-10-24
CA2254871A1 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
PT923308E (pt) Purificacao de peptideos a partir do leite biologicamente activos
TR199901840T2 (xx) DNA'nın cross-flow-filtrasyonu ile temizlenmesi.
ATE310017T1 (de) Verfahren zur reinigung und isolierung von wasserlöslichen peptiden und proteinen aus pflanzenquellen
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
ATE146657T1 (de) Verfahren zur herstellung eines molkeprotein- hydrolysates
DK0764209T3 (da) Albuminekspression i gær
RU2007110534A (ru) Способ концентрирования препаратов антител
DK426386A (da) Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer
ATE62816T1 (de) Verfahren zur herstellung hochgereinigter, stromafreier, hepatitissicherer human- und tierhaemoglobinloesungen.
ES2080210T3 (es) Metodo y sistema para la preparacion de una solucion medica, por ejemplo una solucion de dialisis.
ATE243168T1 (de) Verfahren und vorrichtung zur behandlung von abwasser in einem bioreaktor, einer ultrafiltrationseinheit und einer membranfiltrationeinheit
ATE243067T1 (de) Verfahren zur hohlfasern filtration
TR200003658T2 (tr) Su arıtma cihazı ve metodu
SE8902317L (sv) Saett att rena proteiner
ATE82471T1 (de) Verfahren zur abtrennung bestimmter proteine aus molke.
ATE91304T1 (de) Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.
NO971474D0 (no) Anti-inflammatorisk faktor, fremgangsmåte for isolering, og anvendelse
NO2006006I1 (no) Aktivert protein C
ATE72830T1 (de) Verfahren zur herstellung von gereinigter glukoseisomerase.
DE69734779D1 (de) Erhöhte ausbeuten eines kristallinen proteins durch verwendung eines festen adsorptionsmaterials
ATE91709T1 (de) Verfahren zur entfernung unerwuenschter zellen aus menschlichen lymphozytenpopulationen, anwendung des verfahrens zur herstellung monoklonaler antikoerper und dafuer geeigneter kit.
JPH0353040B2 (cg-RX-API-DMAC7.html)
ES8500059A1 (es) Procedimiento para la produccion de concentrado de factor antihemofilico.
ATE194924T1 (de) Verfahren zur rückgewinnung von rohstoffen bei der herstellung von aspartam